BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $700,945 | -46.1% | 18,573 | -34.9% | 0.01% | -45.0% |
| Q2 2023 | $1,299,462 | +11.3% | 28,522 | -0.9% | 0.02% | +5.3% |
| Q1 2023 | $1,167,276 | +77305.6% | 28,779 | -2.7% | 0.02% | -20.8% |
| Q4 2022 | $1,508 | -99.9% | 29,582 | -4.7% | 0.02% | -14.3% |
| Q3 2022 | $1,672,000 | -40.2% | 31,039 | -28.7% | 0.03% | -36.4% |
| Q2 2022 | $2,798,000 | -18.9% | 43,556 | -2.1% | 0.04% | -4.3% |
| Q1 2022 | $3,451,000 | -10.3% | 44,502 | -0.8% | 0.05% | -6.1% |
| Q4 2021 | $3,849,000 | +144.8% | 44,843 | +129.4% | 0.05% | +40.0% |
| Q3 2021 | $1,572,000 | -2.2% | 19,551 | -2.1% | 0.04% | -5.4% |
| Q2 2021 | $1,607,000 | -2.0% | 19,962 | +2.7% | 0.04% | -7.5% |
| Q1 2021 | $1,639,000 | +0.4% | 19,434 | -4.4% | 0.04% | -9.1% |
| Q4 2020 | $1,632,000 | -11.9% | 20,335 | -5.4% | 0.04% | -22.8% |
| Q3 2020 | $1,852,000 | 0.0% | 21,505 | 0.0% | 0.06% | 0.0% |
| Q2 2020 | $1,852,000 | +4.3% | 21,505 | -1.7% | 0.06% | -10.9% |
| Q1 2020 | $1,775,000 | -6.5% | 21,868 | -3.7% | 0.06% | +23.1% |
| Q4 2019 | $1,899,000 | -17.6% | 22,700 | -13.8% | 0.05% | -5.5% |
| Q3 2019 | $2,304,000 | +4.3% | 26,339 | -2.3% | 0.06% | +1.9% |
| Q2 2019 | $2,208,000 | 0.0% | 26,960 | -0.7% | 0.05% | -19.4% |
| Q1 2019 | $2,208,000 | +34.6% | 27,156 | +8.9% | 0.07% | +34.0% |
| Q4 2018 | $1,641,000 | -15.2% | 24,927 | -0.7% | 0.05% | -13.8% |
| Q3 2018 | $1,936,000 | +8.8% | 25,107 | +4.1% | 0.06% | +1.8% |
| Q2 2018 | $1,780,000 | +4.2% | 24,107 | -8.3% | 0.06% | +3.6% |
| Q1 2018 | $1,709,000 | +0.6% | 26,277 | 0.0% | 0.06% | 0.0% |
| Q4 2017 | $1,699,000 | +3.7% | 26,277 | +0.6% | 0.06% | -1.8% |
| Q3 2017 | $1,639,000 | +3.0% | 26,113 | -0.7% | 0.06% | 0.0% |
| Q2 2017 | $1,592,000 | +13.1% | 26,301 | -3.0% | 0.06% | +14.3% |
| Q1 2017 | $1,407,000 | +13.5% | 27,126 | -3.0% | 0.05% | +6.5% |
| Q4 2016 | $1,240,000 | -8.1% | 27,970 | -1.3% | 0.05% | -14.8% |
| Q3 2016 | $1,349,000 | +2.7% | 28,352 | -2.4% | 0.05% | -1.8% |
| Q2 2016 | $1,313,000 | +1.1% | 29,042 | -8.2% | 0.06% | 0.0% |
| Q1 2016 | $1,299,000 | -0.9% | 31,634 | -8.0% | 0.06% | -3.5% |
| Q4 2015 | $1,311,000 | +5.6% | 34,367 | -9.0% | 0.06% | -21.9% |
| Q3 2015 | $1,241,000 | -56.7% | 37,752 | -7.9% | 0.07% | -44.3% |
| Q2 2015 | $2,867,000 | -5.5% | 40,991 | -7.5% | 0.13% | -4.4% |
| Q1 2015 | $3,035,000 | -2.1% | 44,306 | +4.8% | 0.14% | -1.4% |
| Q4 2014 | $3,099,000 | -74.6% | 42,290 | -75.1% | 0.14% | -76.6% |
| Q3 2014 | $12,196,000 | +421.9% | 169,930 | +425.7% | 0.60% | +436.0% |
| Q2 2014 | $2,337,000 | -11.5% | 32,326 | -10.0% | 0.11% | -25.0% |
| Q1 2014 | $2,642,000 | -15.2% | 35,906 | -19.9% | 0.15% | -13.5% |
| Q4 2013 | $3,117,000 | -2.1% | 44,817 | -7.5% | 0.17% | -7.1% |
| Q3 2013 | $3,183,000 | -13.3% | 48,447 | -8.6% | 0.18% | -14.4% |
| Q2 2013 | $3,670,000 | – | 52,983 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |